Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acid-sensing ion channel 1 (ASIC1) is a H(+)-gated channel of the amiloride-sensitive epithelial Na(+) channel (ENaC)/degenerin family. ASIC1 is expressed mostly in the central and peripheral nervous system neurons. ENaC and ASIC function is regulated by several serine proteases. The type II transmembrane serine protease
matriptase
activates the prototypical alphabetagammaENaC channel, but we found that
matriptase
is expressed in
glioma
cells and its expression is higher in
glioma
compared with normal astrocytes. Therefore, the goal of this study was to test the hypothesis that
matriptase
regulates ASIC1 function. Matriptase decreased the acid-activated ASIC1 current as measured by two-electrode voltage clamp in Xenopus oocytes and cleaved ASIC1 expressed in oocytes or CHO K1 cells. Inactive S805A
matriptase
had no effect on either the current or the cleavage of ASIC1. The effect of
matriptase
on ASIC1 was specific, because it did not affect the function of ASIC2 and no
matriptase
-specific ASIC2 fragments were detected in oocytes or in CHO cells. Three
matriptase
recognition sites were identified in ASIC1 (Arg-145, Lys-185, and Lys-384). Site-directed mutagenesis of these sites prevented
matriptase
cleavage of ASIC1. Our results show that
matriptase
is expressed in
glioma
cells and that
matriptase
specifically cleaves ASIC1 in heterologous expression systems.
...
PMID:Proteolytic cleavage of human acid-sensing ion channel 1 by the serine protease matriptase. 2060 29